COMPASS Pathways plc (CMPS) Financial Statements
Industry: Pharmaceutical Preparations
In fiscal 2025, COMPASS Pathways reported revenue of $0. Net income was -$287.9M, or -$3.08 per diluted share. Operating activities generated -$157.2M of cash. At fiscal year end, COMPASS Pathways held $210.3M in total assets against $263.2M in total liabilities, including $149.6M of cash and equivalents.
Open the full interactive COMPASS Pathways financials → Quarterly statements, key ratios, valuation history and price charts.
COMPASS Pathways Key Stats
| Share Price | $11.14 |
|---|---|
| Market Cap | $1.50B |
| 52-Week Range | $4.94 – $15.19 |
| Shares Outstanding | 135.0 million (basic, 2026 Q2) |
COMPASS Pathways Income Statement
| FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 | $0 |
| Operating Income | -$83.2M | -$110.4M | -$136.9M | -$178.2M | -$179.0M |
| Pre-Tax Income | -$71.5M | -$91.1M | -$117.7M | -$153.5M | -$290.3M |
| Income Tax | $199,000 | $408,000 | $780,000 | $1.6M | -$2.5M |
| Net Income | -$71.7M | -$91.5M | -$118.5M | -$155.1M | -$287.9M |
| Diluted EPS | -$1.79 | -$2.16 | -$2.32 | -$2.30 | -$3.08 |
COMPASS Pathways Quarterly Results
| 2025 Q3 | 2025 Q4 | 2026 Q1 | 2026 Q2 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| Net Income | -$137.7M | -$93.9M | $91.2M | -$253.8M |
| Diluted EPS | -$1.44 | -$1.00 | -$0.30 | -$1.88 |
COMPASS Pathways Balance Sheet
| FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|
| Cash & Equivalents | $273.2M | $143.2M | $220.2M | $165.1M | $149.6M |
| Current Assets | $295.3M | $191.7M | $261.3M | $201.3M | $191.5M |
| Total Assets | $300.9M | $197.3M | $276.0M | $213.7M | $210.3M |
| Current Liabilities | $15.1M | $15.6M | $19.6M | $34.0M | $247.8M |
| Total Long-Term Debt | — | — | $28.8M | $30.2M | $31.6M |
| Total Liabilities | $16.5M | $16.0M | $50.2M | $59.0M | $263.2M |
| Shareholders' Equity | $284.4M | $181.3M | $225.7M | $154.7M | -$52.8M |
COMPASS Pathways Cash Flow Statement
| FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|
| Cash From Operations | -$67.7M | -$105.5M | -$97.4M | -$119.2M | -$157.2M |
| Cash From Investing | -$334,000 | -$596,000 | -$64,000 | $0 | — |
| Cash From Financing | $156.6M | $1.0M | $173.8M | $63.8M | $140.7M |
| Free Cash Flow | -$68.1M | -$106.0M | -$97.4M | -$119.2M | — |
Figures from COMPASS Pathways' 10-K and 10-Q filings with the SEC, as of 2026-10-14. Fiscal years follow the company's own reporting calendar. EPS and share counts are adjusted for later stock splits. See the full COMPASS Pathways financials page for every line item.
COMPASS Pathways Company Profile
| Ticker | CMPS |
|---|---|
| Exchange | Nasdaq |
| Industry | Pharmaceutical Preparations |
| Headquarters | Chesire, United Kingdom |
| Fiscal Year End | December 31 |
| SEC Filer Category | Non-accelerated filer, smaller reporting company |
| SEC CIK | 0001816590 |
Frequently Asked Questions
What was COMPASS Pathways' revenue in fiscal 2025?
COMPASS Pathways (CMPS) reported revenue of $0 for fiscal 2025.
What is COMPASS Pathways' annual revenue history?
COMPASS Pathways' annual revenue by fiscal year: 2021: $0; 2022: $0; 2023: $0; 2024: $0; 2025: $0.
What was COMPASS Pathways' net income in fiscal 2025?
COMPASS Pathways reported net income of -$287.9M for fiscal 2025.
What was COMPASS Pathways' earnings per share (EPS) in fiscal 2025?
COMPASS Pathways' diluted EPS was -$3.08 for fiscal 2025 (adjusted for any later stock splits).
What was COMPASS Pathways' revenue last quarter?
In its most recent reported quarter (2026 Q2), COMPASS Pathways reported revenue of $0.
How much debt does COMPASS Pathways have?
COMPASS Pathways reported $31.6M of long-term debt, including the current portion, at the end of fiscal 2025.
How many shares of COMPASS Pathways are outstanding?
COMPASS Pathways reported a weighted average of 135.0 million basic shares outstanding in 2026 Q2.
What is COMPASS Pathways' market cap?
Based on its latest closing price, COMPASS Pathways (CMPS) has a market capitalization of about $1.50B.
When does COMPASS Pathways' fiscal year end?
COMPASS Pathways' fiscal year end, as registered with the SEC, is December 31.
Where is COMPASS Pathways headquartered?
COMPASS Pathways lists its business address in Chesire, United Kingdom in its SEC filings.